logo
Plus   Neg
Share
Email

Hikma Pharma Completes FDA Response For Generic Advair Diskus

Hikma Pharmaceuticals Plc. (HIK.L, HKMPY.PK) said that it has submitted to the US Food and Drug Administration its response to deficiencies in its abbreviated new drug application for a generic version of GlaxoSmithKline's Advair Diskus.

Hikma initiated a clinical endpoint study in 2018, following receipt of a complete response letter from the FDA.

Siggi Olafsson, Chief Executive Officer of Hikma, said "We are confident in our ability to bring a generic version of Advair to the US market, which would enable us to improve patient access to this important medicine."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Golden Pearl Trading Corp. is recalling certain ready-to-eat or RTE imported Siluriformes products that were produced without benefit of import inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves around 12,054 pounds of Siluriformes products that were not presented for import re-inspection into the United States. The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from...
Follow RTT
>